{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.1150",
  "meta" : {
    "versionId" : "12",
    "lastUpdated" : "2024-01-24T09:53:01.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "NCQA PHEMUR Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-01-24"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-01-24"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1150",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.1150"
    }
  ],
  "version" : "20240124",
  "name" : "SubstanceUseDisorderShortActingMedication",
  "title" : "Substance Use Disorder Short Acting Medication",
  "status" : "active",
  "date" : "2024-01-24T01:11:59-05:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: The purpose of this Grouping value set is to represent concepts for short acting substance use disorder medications.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable Acamprosate, Disulfiram, Naltrexone Oral, Buprenorphine Naloxone and Buprenorphine (oral, sublingual) medications.),(Exclusion Criteria: Excludes concepts that represent non-prescribable or branded drugs and excludes concepts that represent components or ingredients. Excludes long acting implant and injection medications.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.1259"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:03ebf3e4-9f93-4b3b-bcf0-58064c74bbc2",
    "timestamp" : "2024-12-10T10:40:45-05:00",
    "total" : 21,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1010600",
        "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1010604",
        "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1307056",
        "display" : "buprenorphine 4 MG / naloxone 1 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1307061",
        "display" : "buprenorphine 12 MG / naloxone 3 MG Sublingual Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1431076",
        "display" : "buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1431102",
        "display" : "buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1483744",
        "display" : "naltrexone hydrochloride 50 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1542390",
        "display" : "buprenorphine 2.1 MG / naloxone 0.3 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1544851",
        "display" : "buprenorphine 4.2 MG / naloxone 0.7 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1544854",
        "display" : "buprenorphine 6.3 MG / naloxone 1 MG Buccal Film"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1597568",
        "display" : "buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1597573",
        "display" : "buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1666338",
        "display" : "buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1864412",
        "display" : "buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "197623",
        "display" : "disulfiram 250 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "197624",
        "display" : "disulfiram 500 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351264",
        "display" : "buprenorphine 2 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351265",
        "display" : "buprenorphine 8 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351266",
        "display" : "buprenorphine 2 MG / naloxone 0.5 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "351267",
        "display" : "buprenorphine 8 MG / naloxone 2 MG Sublingual Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "835726",
        "display" : "acamprosate calcium 333 MG Delayed Release Oral Tablet"
      }
    ]
  }
}
